Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

X0202 SCHEDULE 13D/A 0001140361-20-014444 0001407737 XXXXXXXX LIVE 7 Common Stock, par value $0.01 per share 09/01/2026 false 0001525221 11040G103 Bristow Group Inc. 3151 BRIARPARK DRIVE, SUITE 700 HOUSTON TX 77042 Christopher Pucillo 212-284-4300 Solus Alternative Asset Management LP 25 Maple Street, 2nd Floor Summit NJ 07901 Ele Klein 212-756-2000 McDermott Will & Schulte LLP 919 Third Avenue New York NY 10022 0001407737 N Solus Alternative Asset Management LP WC OO N DE 0.00 2849710.00 0.00 2849710.00 2849710.00 N 9.61 IA 0001465912 N Solus GP LLC WC OO N DE 0.00 2849710.00 0.00 2849710.00 2849710.00 N 9.61 OO 0001465911 N Christopher Pucillo WC OO N X1 0.00 2849710.00 0.00 2849710.00 2849710.00 N 9.61 IN Common Stock, par value $0.01 per share Bristow Group Inc. 3151 BRIARPARK DRIVE, SUITE 700 HOUSTON TX 77042 This Amendment No. 7 ("Amendment No. 7") amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on June 22, 2020 (the "Original Schedule 13D", and the Original Schedule 13D as amended, the "Schedule 13D"), with respect to shares of common stock, par value $0.01 per share (the "Common Stock"), of Bristow Group Inc., a Delaware corporation (the "Issuer"). This Amendment No. 7 amends and restates Items 5(a)-(c) as set forth below. Capitalized terms used herein and not otherwise defined in this Amendment No. 7 have the meanings set forth in the Schedule 13D. See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and the percentage of the Common Stock beneficially owned by each of the Reporting Persons. The percentage reported in this Schedule 13D is calculated based upon 29,642 thousand shares of Common Stock outstanding as of July 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the SEC on August 5, 2026. See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. The transactions in the shares of Common Stock within the past sixty (60) days by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. Solus Alternative Asset Management LP /s/ Christopher Pucillo Christopher Pucillo, Managing Member of GP, General Partner of Solus 09/03/2026 Solus GP LLC /s/ Christopher Pucillo Christopher Pucillo, Managing Member of GP 09/03/2026 Christopher Pucillo /s/ Christopher Pucillo Christopher Pucillo, Individually 09/03/2026